Previous studies have shown that the level of IDE protein in the brain of AD patients is reduced, and the activity of IDE protein is negatively correlated with the level of Aβ1–42 (Pérez et al., 2000; Zhao et al., 2007). The gene discussed is IDE; the disease is Alzheimer disease.